Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP785104.RAN5muvteyh_dxt8X3gDFNwBs-qyzASIHxBw1xIzP5-1E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP785104.RAN5muvteyh_dxt8X3gDFNwBs-qyzASIHxBw1xIzP5-1E130_assertion type Assertion NP785104.RAN5muvteyh_dxt8X3gDFNwBs-qyzASIHxBw1xIzP5-1E130_head.
- NP785104.RAN5muvteyh_dxt8X3gDFNwBs-qyzASIHxBw1xIzP5-1E130_assertion description "[In the present CAD population, no differences in circulating levels of fractalkine or expression levels of CX3CR1 were observed between patients with and without T2DM, or with and without metabolic syndrome, which may be related to their underlying disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP785104.RAN5muvteyh_dxt8X3gDFNwBs-qyzASIHxBw1xIzP5-1E130_provenance.
- NP785104.RAN5muvteyh_dxt8X3gDFNwBs-qyzASIHxBw1xIzP5-1E130_assertion evidence source_evidence_literature NP785104.RAN5muvteyh_dxt8X3gDFNwBs-qyzASIHxBw1xIzP5-1E130_provenance.
- NP785104.RAN5muvteyh_dxt8X3gDFNwBs-qyzASIHxBw1xIzP5-1E130_assertion SIO_000772 22897138 NP785104.RAN5muvteyh_dxt8X3gDFNwBs-qyzASIHxBw1xIzP5-1E130_provenance.
- NP785104.RAN5muvteyh_dxt8X3gDFNwBs-qyzASIHxBw1xIzP5-1E130_assertion wasDerivedFrom befree-20140225 NP785104.RAN5muvteyh_dxt8X3gDFNwBs-qyzASIHxBw1xIzP5-1E130_provenance.
- NP785104.RAN5muvteyh_dxt8X3gDFNwBs-qyzASIHxBw1xIzP5-1E130_assertion wasGeneratedBy ECO_0000203 NP785104.RAN5muvteyh_dxt8X3gDFNwBs-qyzASIHxBw1xIzP5-1E130_provenance.